Clinical Trial Update: Lactobacillus Lozenges as Preventative Care in Low-grade Dysplasia [Phase 3]

View source ↗

Summary

Phase 3 trial of Lactobacillus lozenges for preventing progression in low-grade oral epithelial dysplasia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Epithelial Dysplasia

Drugs mentioned

• Lactobacillus lozenges (Lactobacillus sp. probiotic lozenge)

Snippet

Sponsor: Boston Medical Center | Conditions: Low-grade Oral Dysplasia | Phase 3 | Status: WITHDRAWN